A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A Phase III Double Blinded, Randomized Controlled Study to Evaluate Efficacy of Protection Against HPV-16 and 18 Related Diseases, Immunogenicity and Safety of Recombinant Human Papillomavirus Virus-like Particle Vaccine (Type 16 and 18 L1 Proteins, Yeast) in Healthy Females Aged 18-30 Years.
Epistemonikos ID: 3b805b92d1a7e4e26b247936909cd308729d5584
First added on: Mar 23, 2020